Sherly Mosessian

773 citations
12 papers · 627 indexed · h-index 8
Topics
PI3K/AKT/mTOR signaling in cancer (4 papers)Neuroendocrine Tumor Research Advances (2 papers)Peptidase Inhibition and Analysis (2 papers)

In The Last Decade

Sherly Mosessian

12 papers receiving 620 citations

Peers

Sherly Mosessian
Comparison fields: 5 of 71
  • Molecular Biology 423
  • Oncology 144
  • Hematology 84
  • Immunology 75
  • Virology 68
Replace Kelli Oswald with:
Kelli Oswald United States
Aloke Sarkar United States
Boris Brill Germany
R. Masood United States
Oliver Feyen Germany
Ramona Ilari Italy
Manuela Bragardo Italy
CN Abboud United States
Susan E. Lim United States
M Allouche France
Sherly Mosessian relative to Kelli Oswald United States Kelli Oswald's profile →
Citations per field
00.5×1.5×2.5×
Kelli Oswald · 1×
Citations per year

Countries citing papers authored by Sherly Mosessian

Since Specialization
Citations

This map shows the geographic impact of Sherly Mosessian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherly Mosessian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherly Mosessian more than expected).

Fields of papers citing papers by Sherly Mosessian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sherly Mosessian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherly Mosessian. The network helps show where Sherly Mosessian may publish in the future.

Co-authorship network of co-authors of Sherly Mosessian

This figure shows the co-authorship network connecting the top 25 collaborators of Sherly Mosessian. A scholar is included among the top collaborators of Sherly Mosessian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sherly Mosessian. Sherly Mosessian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 5
2 5
3 4
4 55
5 18
6 58
7 61
8
PTEN-Associated Complexes: An Overview.
1
9 18
10 90
11 192
12 120

About Sherly Mosessian

Sherly Mosessian is a scholar working on Virology, Oncology and Hematology, having authored 12 papers that have together received 627 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (4 papers), Neuroendocrine Tumor Research Advances (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Virology (68 citations), Hematology (84 citations) and Molecular Biology (423 citations). Sherly Mosessian has collaborated with scholars based in United States, Germany and Poland. Frequent co-authors include Hong Wu, Chun-Ju Chang, Bahram Valamehr, Samson A. Chow, Cora L. Woodward, David J. Mulholland, Marileila Varella‐Garcia, William R. Sellers, Xiaoman Lewis and Jennifer Yeh. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026